Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063464 · ClinicalTrials.gov registry record
Blood Collection From People With Ovarian Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 85
- Enrollment target
NCT02063464: Completed study, sponsored by National Cancer Institute (NCI).
NCT02063464 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02063464 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
Background: * Monocytes are a type of white blood cell found in human blood. They help the immune system. Researchers have found that monocytes taken from the blood of healthy people can kill tumor cells. Now they want to know if monocytes taken from the blood of people with ovarian cancer can kill tumor cells. * In addition, native host anti-tumor cell mediated immune mechanisms may play a role in clinical outcome of epithelial ovarian cancer; data indicate that the presence of intra-tumoral CD3+ T-cells was shown to prognosticate improved outcome in advanced ovarian cancer. Furthermore, non-cellular components in the blood, such as exosomes, may influence outcome. Objective: \- To see if monocytes taken from the blood of people with ovarian cancer can kill tumor cells. Eligibility: \- Women 18 years and older with ovarian cancer. Design: * Participants will be screened with: * Medical history and physical exam. * Blood tests. * CT scan of the chest, abdomen, and pelvis and/or an MRI. For these scans, they will lie in a machine that takes pictures of their body. * A small amount of blood (two tubes) will be collected by needle during one visit.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2014-03-10 |
| Est. Completion | 2016-11-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02063464
The ClinicalTrials.gov registry entry for NCT02063464 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02063464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02063464 about?
NCT02063464 is a clinical study titled "Blood Collection From People With Ovarian Cancer". Background: * Monocytes are a type of white blood cell found in human blood. They help the immune system. Researchers have found that monocytes taken from the blood of healthy people can kill tumor cells. Now they want to know if monocytes taken from the blood of people with ovarian cancer can kill...
What is the current status of trial NCT02063464?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2014-03-10. Estimated completion is 2016-11-16.
Who is sponsoring clinical trial NCT02063464?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.